Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Johnston

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Trials|November 18, 2021
Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAAMatthew J Swanson, James L Johnston, Joseph S Ross
Scientific Reports|May 28, 2017
The pPSU Plasmids for Generating DNA Molecular Weight MarkersRyan C Henrici, Turner J Pecen, James L Johnston, et al.
JAMA Cardiology|October 25, 2023
Aligning US Agency Policies for Cardiovascular Devices Through the Breakthrough Devices ProgramOsman Moneer, Vinay K Rathi, James L Johnston, et al.
JAMA Health Forum|November 15, 2024
Medical Devices Applying for Outpatient Medicare Supplemental PaymentsOsman Moneer, James L Johnston, Vinay K Rathi, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|September 25, 2015
Perioperative Complications in Posterior Pharyngeal Flap Surgery: Review of the National Surgical Quality Improvement Program Pediatric (NSQIP-PEDS) DatabaseJordan W Swanson, James L Johnston, Brianne T Mitchell, et al.
Cellular and Molecular Bioengineering|August 21, 2018
Cardiovascular function and structure are preserved despite induced ablation of BMP1-related proteinasesMark J Golob, Dawiyat Massoudi, Diana M Tabima, et al.
JAMA Internal Medicine|June 30, 2025
FDA Authorization of Therapeutic Devices Under the Breakthrough Devices ProgramKushal T Kadakia, Sanket S Dhruva, Joseph S Ross, et al.
Journal of Biomechanics|March 7, 2017
Pulmonary arterial strain- and remodeling-induced stiffening are differentiated in a chronic model of pulmonary hypertensionMark J Golob, Diana M Tabima, Gregory D Wolf, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Trials|November 18, 2021
Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAAMatthew J Swanson, James L Johnston, Joseph S Ross
Scientific Reports|May 28, 2017
The pPSU Plasmids for Generating DNA Molecular Weight MarkersRyan C Henrici, Turner J Pecen, James L Johnston, et al.
JAMA Cardiology|October 25, 2023
Aligning US Agency Policies for Cardiovascular Devices Through the Breakthrough Devices ProgramOsman Moneer, Vinay K Rathi, James L Johnston, et al.
JAMA Health Forum|November 15, 2024
Medical Devices Applying for Outpatient Medicare Supplemental PaymentsOsman Moneer, James L Johnston, Vinay K Rathi, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|September 25, 2015
Perioperative Complications in Posterior Pharyngeal Flap Surgery: Review of the National Surgical Quality Improvement Program Pediatric (NSQIP-PEDS) DatabaseJordan W Swanson, James L Johnston, Brianne T Mitchell, et al.
Cellular and Molecular Bioengineering|August 21, 2018
Cardiovascular function and structure are preserved despite induced ablation of BMP1-related proteinasesMark J Golob, Dawiyat Massoudi, Diana M Tabima, et al.
JAMA Internal Medicine|June 30, 2025
FDA Authorization of Therapeutic Devices Under the Breakthrough Devices ProgramKushal T Kadakia, Sanket S Dhruva, Joseph S Ross, et al.
Journal of Biomechanics|March 7, 2017
Pulmonary arterial strain- and remodeling-induced stiffening are differentiated in a chronic model of pulmonary hypertensionMark J Golob, Diana M Tabima, Gregory D Wolf, et al.
Pageof 1